INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

The FINANCIAL — Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL; U-200), the first and only concentrated mealtime insulin analog in the U.S., is now available in pharmacies, Eli Lilly and ...

Humalog (insulin lispro) is a prescription drug that’s prescribed for diabetes in adults and certain children. The drug comes as a liquid solution for subcutaneous injection or intravenous (IV) ...

Humalog (insulin lispro) is a prescription medication used to manage blood sugar levels in people with type 1 and type 2 diabetes. Your doctor will determine the appropriate dosage of Humalog based on ...

KwikPen, a prefilled, portable insulin pen for use with Lilly’s Humalog (insulin lispro injection [rDNA origin]) brand of insulins, is now available. KwikPens do not require refrigeration after the ...

NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

Humalog (insulin lispro) is a prescription drug that’s used to help treat diabetes. Humalog comes as a liquid solution for infusion or injection under the skin. Humalog comes in two versions: Humalog ...

Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen. The Humalog Junior KwikPen (insulin lispro; Eli Lilly), a ...

The International Monetary Fund cut its growth outlook to 3.1% due to the Middle East war but said the world was already drifting toward a more adverse scenario. Reuters, the news and media division ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...